These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33206135)

  • 1. Pain Severity and Management of Hidradenitis Suppurativa at US Emergency Department Visits.
    Taylor MT; Orenstein LAV; Barbieri JS
    JAMA Dermatol; 2021 Jan; 157(1):115-117. PubMed ID: 33206135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain Management in Patients With Hidradenitis Suppurativa Requiring Surgery.
    Puza CJ; Wolfe SA; Jaleel T
    Dermatol Surg; 2019 Oct; 45(10):1327-1330. PubMed ID: 30570515
    [No Abstract]   [Full Text] [Related]  

  • 3. Pain in Hidradenitis Suppurativa: A Pilot Study.
    Ring HC; Sørensen H; Miller IM; List EK; Saunte DM; Jemec GB
    Acta Derm Venereol; 2016 May; 96(4):554-6. PubMed ID: 26631388
    [No Abstract]   [Full Text] [Related]  

  • 4. Expert Knowledge, Attitudes, and Practices in Management of Hidradenitis Suppurativa Pain.
    Jedrzejczak MJ; Ingram JR; Lowes MA; Naik HB; McKenzie-Brown AM; Chen SC; Orenstein LAV
    JAMA Dermatol; 2021 Apr; 157(4):464-466. PubMed ID: 33625467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study.
    Molinelli E; Brisigotti V; Campanati A; Sapigni C; Giacchetti A; Cota C; Offidani A
    J Am Acad Dermatol; 2020 Aug; 83(2):665-667. PubMed ID: 32339699
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of hidradenitis suppurativa on work productivity and associated risk factors.
    van Straalen KR; Prens LM; Hylkema TH; Janse IC; Dickinson J; Houwing R; van der Zee HH; Brouwer S; Prens EP; Horváth B
    J Am Acad Dermatol; 2021 May; 84(5):1401-1405. PubMed ID: 32763324
    [No Abstract]   [Full Text] [Related]  

  • 7. Perceived stress in four inflammatory skin diseases: an analysis of data taken from 7273 adult subjects with acne, atopic dermatitis, psoriasis or hidradenitis suppurativa.
    Misery L; Chesnais M; Merhand S; Aubert R; Bru MF; Legrand C; Raynal H; Taieb C; Richard MA
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e623-e626. PubMed ID: 35181931
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report.
    Thorlacius L; Theut Riis P; Jemec GBE
    Br J Dermatol; 2018 Jul; 179(1):182-185. PubMed ID: 28654150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain management in patients with hidradenitis suppurativa.
    Horváth B; Janse IC; Sibbald GR
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S47-51. PubMed ID: 26470616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa.
    Ravn Jørgensen AH; Yao Y; Thomsen SF; Christian Ring H
    Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):153-158. PubMed ID: 33232705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic drugs during COVID-19 outbreak.
    Montesu MA; Biondi G; Sotgiu G; Sucato F; Satta R
    Int J Dermatol; 2020 Oct; 59(10):1293. PubMed ID: 32767379
    [No Abstract]   [Full Text] [Related]  

  • 12. Hidradenitis Suppurativa: New Opportunities for an Orphan Skin Disease.
    Carrascosa JM; Bassas J; Puig L
    Actas Dermosifiliogr; 2015; 106(6):448-51. PubMed ID: 25796270
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa.
    Khalsa A; Liu G; Kirby JS
    J Am Acad Dermatol; 2015 Oct; 73(4):609-14. PubMed ID: 26190241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of opioid analgesics on emergency department length of stay among low back pain patients in the United States.
    Anderson SW; Bhattacharjee S; Patanwala AE
    Am J Emerg Med; 2020 Sep; 38(9):1802-1806. PubMed ID: 32739851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported pain management in hidradenitis suppurativa.
    Ring HC; Theut Riis P; Miller IM; Saunte DM; Jemec GB
    Br J Dermatol; 2016 Apr; 174(4):909-11. PubMed ID: 26521975
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid Prescriptions for Acute and Chronic Pain Management Among Medicaid Beneficiaries.
    Janakiram C; Fontelo P; Huser V; Chalmers NI; Lopez Mitnik G; Brow AR; Iafolla TJ; Dye BA
    Am J Prev Med; 2019 Sep; 57(3):365-373. PubMed ID: 31377093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: The importance of a psychodermatological approach.
    Iannone M; Janowska A; Panduri S; Morganti R; Davini G; Romanelli M; Dini V
    Exp Dermatol; 2022 Jun; 31(6):956-961. PubMed ID: 35285091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in prescription opioid use in pediatric emergency department patients.
    Mazer-Amirshahi M; Mullins PM; Rasooly IR; van den Anker J; Pines JM
    Pediatr Emerg Care; 2014 Apr; 30(4):230-5. PubMed ID: 24651218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States.
    McMillan K
    Am J Epidemiol; 2014 Jun; 179(12):1477-83. PubMed ID: 24812161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse-initiated oral opioid pain protocol improves the quality of musculoskeletal pain management in the emergency department.
    Caspi S; Meidan R; Peless E; Raizman E
    Int Emerg Nurs; 2019 Mar; 43():29-33. PubMed ID: 30031736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.